Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-29,253
Closed -$2.91M 668
2025
Q2
$2.91M Buy
29,253
+5,430
+23% +$441K 0.01% 687
2025
Q1
$1.91M Sell
23,823
-9,456
-28% -$955K 0.01% 743
2024
Q4
$3.47M Buy
33,279
+19,521
+142% +$2.11M 0.01% 638
2024
Q3
$1.5M Buy
13,758
+4,259
+45% +$506K ﹤0.01% 805
2024
Q2
$1.24M Hold
9,499
﹤0.01% 847
2024
Q1
$1.26M Sell
9,499
-7,974
-46% -$927K ﹤0.01% 815
2023
Q4
$1.8M Buy
+17,473
New +$1.42M 0.01% 761
2021
Q3
Sell
-31,500
Closed -$5.61M 1286
2021
Q2
$5.61M Sell
31,500
-22,900
-42% -$4.16M 0.02% 676
2021
Q1
$10.1M Sell
54,400
-55,300
-50% -$9.29M 0.03% 515
2020
Q4
$16.5M Sell
109,700
-10,100
-8% -$1.32M 0.05% 373
2020
Q3
$13.1M Buy
+119,800
New +$14M 0.05% 378
2019
Q1
Sell
-14,000
Closed -$905K 1358
2018
Q4
$905K Sell
14,000
-136,023
-91% -$9.83M ﹤0.01% 986
2018
Q3
$12M Sell
150,023
-24,134
-14% -$2.2M 0.04% 423
2018
Q2
$16.7M Sell
174,157
-17,966
-9% -$1.96M 0.06% 323
2018
Q1
$22.2M Sell
192,123
-30,977
-14% -$3.4M 0.09% 265
2017
Q4
$21.1M Buy
223,100
+44,500
+25% +$4.43M 0.08% 286
2017
Q3
$16.9M Buy
178,600
+38,900
+28% +$3.18M 0.07% 308
2017
Q2
$9.4M Buy
+139,700
New +$10.6M 0.04% 439
2014
Q4
Sell
-29,300
Closed -$978K 1444
2014
Q3
$978K Buy
+29,300
New +$959K ﹤0.01% 910

Other funds holding MKSI

Axa's MKSI Position: Q3 2025 in Review

Axa sold out of MKS Inc (MKSI) in Q3 2025, closing a stake of 29,253 shares — an estimated $2.91M sold.

Axa first reported a position in MKSI in Q3 2014 and held it in 19 quarters. The position peaked at $22.2M in Q1 2018. 433 funds tracked by Wall St. Rank hold MKSI as of Q3 2025.

  • Axa reported no remaining MKS Inc position as of Q3 2025 after selling out during the quarter.
  • Axa sold 29,253 MKS Inc shares in Q3 2025, an estimated $2.91M.
  • Axa first reported a position in MKS Inc in Q3 2014 and held it in 19 quarters.
  • Axa's MKS Inc position peaked at $22.2M in Q1 2018.
  • 433 funds tracked by Wall St. Rank held MKS Inc as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.